Clinical utility of positron emission tomography in the diagnosis and management of periampullary neoplasms

2002 ◽  
Vol 9 (8) ◽  
pp. 799-806 ◽  
Author(s):  
Matthew F. Kalady ◽  
Bryan M. Clary ◽  
Lisa A. Clark ◽  
Marcia Gottfried ◽  
Eric M. Rohren ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
Clinical Utility ◽  
Emission Tomography ◽  
Diagnosis And Management ◽  
Positron Emission ◽  
Periampullary Neoplasms

scholarly journals A Review of Diagnostic Impact of Amyloid Positron Emission Tomography Imaging in Clinical Practice

2018 ◽  
Vol 46 (3-4) ◽  
pp. 154-167 ◽  
Author(s):  
Yejin Kim ◽  
Paul Rosenberg ◽  
Esther Oh
Keyword(s):  
Positron Emission Tomography ◽  
Clinical Practice ◽  
Pet Imaging ◽  
Clinical Utility ◽  
Patient Management ◽  
Emission Tomography ◽  
Amyloid Pet ◽  
Diagnostic Confidence ◽  
Positron Emission ◽  
Amyloid Pet Imaging

Background: Molecular imaging of brain amyloid for the diagnosis of Alzheimer’s disease (AD) using positron emission tomography (PET) has been approved for use in clinical practice by the Food and Drug Administration (FDA) since 2012. However, the clinical utility and diagnostic impact of amyloid PET imaging remain controversial. We conducted a review of the recent studies investigating clinical utility of amyloid PET imaging with focus on changes in diagnosis, diagnostic confidence, and patient management. Summary: A total of 16 studies were included in the final analysis. Overall rate of changes in diagnosis after amyloid PET ranged from 9 to 68% (pooled estimate of 31%, 95% CI 23–39%). All studies reported overall increase in diagnostic confidence or diagnostic certainty after amyloid PET. Changes in patient management ranged from 37 to 87%; the most common type of change in management reported was either the initiation or discontinuation of planned AD medications. Key Messages: Amyloid PET imaging led to moderate to significant changes in diagnosis, diagnostic confidence, and subsequent patient management. It may be most useful in patients with high level of diagnostic uncertainty even after the completing the standard workup.

Positron Emission Tomography in the Diagnosis and Management of Intracranial Germ Cell Tumours

2009 ◽  
Vol 72 (3) ◽  
pp. 190-196 ◽  
Author(s):  
Philip A. Kelly ◽  
Karl Metcalfe ◽  
Jane Evanson ◽  
Ian Sabin ◽  
P. Nicholas Plowman ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
Germ Cell ◽  
Emission Tomography ◽  
Germ Cell Tumours ◽  
Diagnosis And Management ◽  
Positron Emission

scholarly journals The Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Prognostication, Diagnosis, and Management of Thyroid Carcinoma

2012 ◽  
Vol 2012 ◽  
pp. 1-8 ◽  
Author(s):  
Brian Hung-Hin Lang
Keyword(s):  
Positron Emission Tomography ◽  
Thyroid Carcinoma ◽  
Fdg Pet ◽  
Emission Tomography ◽  
Fluorodeoxyglucose Positron Emission Tomography ◽  
Diagnosis And Management ◽  
18F Fluorodeoxyglucose ◽  
Radioiodine Ablation ◽  
Positron Emission ◽  
Fluorodeoxyglucose Positron Emission

18F-fluorodeoxyglucose positron emission tomography (FDG-PET) plays an increasingly important role in the prognostication, diagnosis, and management of thyroid carcinoma. For patients diagnosed with primary or persistent/recurrent thyroid carcinoma, a finding of FDG-PET positivity implies a more aggressive tumor biology and a distinct mutational profile, both of which carry prognostic significance. Therefore, FDG-PET positivity may be a useful potential risk factor for preoperative risk stratification in primary thyroid carcinoma. This information may help in the planning of subsequent treatment strategy such as the extent of thyroidectomy, prophylactic central neck dissection, and radioiodine ablation. FDG-PET scan has also been found to be a useful adjunct in characterizing indeterminate thyroid nodules on fine needle aspiration cytology. However, larger-sized prospective studies are required to validate this finding. FDG-PET or FDG-PET/CT scan has become the imaging of choice in patients with a negative whole-body radioiodine scan, but with an abnormally raised thyroglobulin level after total thyroidectomy and radioiodine ablation.

The Utility of Positron Emission Tomography Scans in the Diagnosis and Management of Pancreatic Adenocarcinoma

2011 ◽  
Vol 140 (5) ◽  
pp. S-1021-S-1022
Author(s):  
Megan D. Winner ◽  
Minna K. Lee ◽  
Joseph DiNorcia ◽  
James A. Lee ◽  
Beth Schrope ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
Pancreatic Adenocarcinoma ◽  
Emission Tomography ◽  
Diagnosis And Management ◽  
Positron Emission
Sign in / Sign up

Export Citation Format

Share Document